NCT03965936

Brief Summary

this research is to study the effect of Adipose Derived Stem Cells on Survival of Fat as Filler

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 29, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 16, 2019

Completed
Last Updated

July 18, 2019

Status Verified

July 1, 2019

Enrollment Period

7 months

First QC Date

May 24, 2019

Last Update Submit

July 16, 2019

Conditions

Keywords

adipose tissue derived stem cellslipofilling

Outcome Measures

Primary Outcomes (1)

  • Assessment using hollowness severity rating scale :0 : no visible hollowness, 1: mild Hollowness, 2 : moderate Hollowness, 3: severe Hollowness

    serial photography for assessment using hollowness severity rating scale :0 : no visible hollowness, 1: mild Hollowness, 2 : moderate Hollowness, 3: severe Hollowness

    3 months, 6 months

Secondary Outcomes (2)

  • Measurement of hypodermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head

    3 months, 6 months

  • Measurement of dermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head Measurement of dermal thickness in mm using UBM (Ultrasound Bio microscopy) on both temple regions of the head

    3 months, 6 months

Study Arms (2)

lipofilling

PLACEBO COMPARATOR

subcutaneous injection of lipoaspiate (microfat) in one temporal region

Procedure: lipofilling

lipofilling enriched with adipose tissue derived stem cells

ACTIVE COMPARATOR

subcutaneous injection of lipoaspiate enriched with adipose tissue derived stem cells in one temporal region

Procedure: lipofilling enriched with adipose tissue derived stem cells

Interventions

lipofillingPROCEDURE

Under local anesthesia using strict aseptic technique, a small incision will be done in the lateral aspect of the thigh or lower abdomen, through which the infiltration cannula will be introduced to inject the local anesthetic solution using the wet technique. This will be followed 15 minutes later by lipo-aspiration of 75 ml fat ) using a blunt tipped cannula under the negative suction pressure of a 60 ml syringe. 50 ml is used for preparation of microfat. then with blunt cannula,subcutaneous injection of the required volume of microfat is placed into temporal region.

lipofilling

Under local anesthesia using strict aseptic technique, a small incision will be done in the lateral aspect of the thigh or lower abdomen, through which the infiltration cannula will be introduced to inject the local anesthetic solution using the wet technique. This will be followed 15 minutes later by lipo-aspiration of 75 ml fat using a blunt tipped cannula under the negative suction pressure of a 60 ml syringe. 50 ml is used for preparation of microfat. 25 ml is used for preparation of autologous adipose tissue derived stem cells (At-ADSCs) using enzymatic digestion and differential centrifugation in the Center of Excellence for Research in Regenerative Medicine and its Application (CERRMA), Alexandria Faculty of Medicine. Subcutaneous injection of the required volume of microfat combined with stromal vascular fraction containing adipose tissue derived stem cells, is placed into temporal region.

lipofilling enriched with adipose tissue derived stem cells

Eligibility Criteria

Age35 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically diagnosed facial skin aging.
  • Glogau photoaging score II and III.
  • Body mass index ≥20 with adequate abdominal or other subcutaneous adipose tissue accessible for lipoaspiration.

You may not qualify if:

  • History of keloid formation.
  • Any coincidental chronic illness (e.g. metabolic, autoimmune or endocrinal) or malignancy.
  • Any bleeding or coagulation disorder or recent use of anticoagulant therapy.
  • Active infection.
  • History of any previous aesthetic procedure on the face within the past 6 months.
  • History of intake of anti-aging systemic or topical medications within the previous 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aliaa Ismail

Alexandria, 21521, Egypt

Location

Related Publications (1)

  • Roshdy OH, Abdallah WI, Farid CI, Mehanna RA, Bayoumi NH, Ismail AI. Stromal vascular fraction improves the durability of autologous fat temple augmentation-A split-face randomized study using ultrasound biomicroscopy. J Plast Reconstr Aesthet Surg. 2022 Jun;75(6):1870-1877. doi: 10.1016/j.bjps.2021.12.005. Epub 2022 Jan 15.

Study Officials

  • Carmen Ibrahim Farid Mohammed Amin, MD

    Assistant Professor of Dermatology, Faculty of Medicine, Alexandria University.

    STUDY DIRECTOR
  • Ossama Hussein Roshdy, MD

    Professor of Dermatology, Faculty of Medicine, University of Alexandria.

    STUDY DIRECTOR
  • Wafaa Ibrahim Abdullah, MD

    Professor of Dermatology, Faculty of Medicine, University of Alexandria.

    STUDY DIRECTOR
  • Radwa Ali Mehanna, PhD

    Assistant Professor of Physiology, Faculty of Medicine, Alexandria University

    STUDY DIRECTOR
  • Nader Hussein Lotfy Bayoumi., MD, FRCS

    Professor of ophthalmology , Faculty of Medicine, University of Alexandria.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: split face
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

May 24, 2019

First Posted

May 29, 2019

Study Start

January 1, 2019

Primary Completion

July 16, 2019

Study Completion

July 16, 2019

Last Updated

July 18, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations